Future of IVD Marketplace (E-commerce) Platforms, 2022

Future of IVD Marketplace (E-commerce) Platforms, 2022

Opportunity to Create Disruptive Differentiation in 'Supply chain management' by harnessing E-commerce marketplace.

Expected RELEASE DATE
07-Jul-2022
REGION
Global
Research Code: K789-01-00-00-00
SKU: HC03549-GL-MR_26609

$6,000.00

Special Price $5,400.00 save 10 %

In stock
SKU
HC03549-GL-MR_26609

$6,000.00

$5,400.00 save 10 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Diagnostics are central to effective health care but still are not accessible to all. As Lancet 2020 study states 47% of the global population has little to no access to diagnostic, bringing in more emphasis equitable distribution across geographies and containing costs of procurement. During the pandemic there has been an increase in demand for personal protective equipment (PPE), consumables for Molecular Diagnostics (MDx), vaccines, POCT testing for SARS-Cov2. However, supply and logistics had glitches due to poor procurement causing manufacturing delays thus becoming the biggest expense in diagnostics and healthcare. Vendors of R&D, prototyping, and small-batch manufacturing services, niche testing labs, suffered the largest decrease in revenue across segments of the value chain. Pandemic has jump started the use of technology - the digitalization of healthcare. The technology play is seen to benefit the entire healthcare. Engineering and technological innovations especially in ecommerce has provided solutions to the diagnostic world emphasizing that global connectivity, transparency, access, scalability, cost efficiencies can reduce the diagnostic gap, improve access, and democratize diagnostics to empower providers, payers and patients. Diagnostics are central to effective health care but still are not accessible to all. As Lancet 2020 study states 47% of the global population has little to no access to diagnostic, bringing in more emphasis equitable distribution across geographies and containing costs of procurement. During the pandemic there has been an increase in demand for personal protective equipment (PPE), consumables for Molecular Diagnostics (MDx), vaccines, POCT testing for SARS-Cov2. However, supply and logistics had glitches due to poor procurement causing manufacturing delays thus becoming the biggest expense in diagnostics and healthcare. Vendors of R&D, prototyping, and small-batch manufacturing services, niche testing labs, suffered the largest decrease in revenue across segments of the value chain. Pandemic has jump started the use of technology - the digitalization of healthcare. The technology play is seen to benefit the entire healthcare. Engineering and technological innovations especially in ecommerce has provided solutions to the diagnostic world emphasizing that global connectivity, transparency, access, scalability, cost efficiencies can reduce the diagnostic gap, improve access, and democratize diagnostics to empower providers, payers and patients. The lessons learnt from the COVID 19 Pandemic in 2020, 2021 has emphasized of building blocks of health systems such as timely health service delivery, attention to health workforce, need or robust health information systems, access to diagnostics (analogous to essential medicines), equitable and efficient supply chain for procurement and supplies, both, seamless communication and interconnectedness, financing, leadership and governance. The COVID-19 pandemic has emphasized about the crucial role of diagnostics in health care and that without access to diagnostics, delivery of universal health coverage, antimicrobial resistance mitigation, and pandemic preparedness cannot be achieved. The demand for testing in the pandemic has fueled online commerce demand, forcing IVD companies, OEMs, distributors, laboratories to strategize its business operations differently. The new retail business models in e commerce marketplace such as B2B, B2B2C, B2C are redefining the in vitro diagnostics market. It enables global IVD OEMs, distributors, suppliers, laboratories, e- pharmacies to supply and healthcare institutions, hospitals, clinics, and other healthcare facilities to purchase diagnostic tests, medical equipment and supplies through online channels. In Vitro Diagnostic E-commerce includes buying, selling, leasing, outsourcing of diagnostic equipment, instruments, diagnostic tests, POCT devices and service information which offers advantages such as convenience, lower prices & discounts, across wide range of products, replacement & refund policies, reviews & feedbacks, and quality certifications, thus providing seamless, real time access to R&D, Manufacturing , Supply chain functions of organizations, saving time, connects for quality, state-of-art equipment and products ( and service information). The IVD market is buoyant due to high demand in products, molecular diagnostics, immunoassays, POCT in chronic diseases, rise in consumerization and telehealth (tele-pharmacy), all are strongly pushing it towards further digitalization with latest technology such as AI, ML, IoT. The study will unravel all the strategies and market models for success in E commerce marketplace and online platforms

Diagnostics are central to effective health care but still are not accessible to all. As Lancet 2020 study states 47% of the global population has little to no access to diagnostic, bringing in more emphasis equitable distribution across geographies and containing costs of procurement. During the pandemic there has been an increase in demand for personal protective equipment (PPE), consumables for Molecular Diagnostics (MDx), vaccines, POCT testing for SARS-Cov2. However, supply and logistics had glitches due to poor procurement causing manufacturing delays thus becoming the biggest expense in diagnostics and healthcare. Vendors of R&D, prototyping, and small-batch manufacturing services, niche testing labs, suffered the largest decrease in revenue across segments of the value chain. Pandemic has jump started the use of technology - the digitalization of healthcare. The technology play is seen to benefit the entire healthcare. Engineering and technological innovations especially in ecommerce has provided solutions to the diagnostic world emphasizing that global connectivity, transparency, access, scalability, cost efficiencies can reduce the diagnostic gap, improve access, and democratize diagnostics to empower providers, payers and patients. Diagnostics are central to effective health care but still are not accessible to all. As Lancet 2020 study states 47% of the global population has little to no access to diagnostic, bringing in more emphasis equitable distribution across geographies and containing costs of procurement. During the pandemic there has been an increase in demand for personal protective equipment (PPE), consumables for Molecular Diagnostics (MDx), vaccines, POCT testing for SARS-Cov2. However, supply and logistics had glitches due to poor procurement causing manufacturing delays thus becoming the biggest expense in diagnostics and healthcare. Vendors of R&D, prototyping, and small-batch manufacturing services, niche testing labs, suffered the largest decrease in revenue across segments of the value chain. Pandemic has jump started the use of technology - the digitalization of healthcare. The technology play is seen to benefit the entire healthcare. Engineering and technological innovations especially in ecommerce has provided solutions to the diagnostic world emphasizing that global connectivity, transparency, access, scalability, cost efficiencies can reduce the diagnostic gap, improve access, and democratize diagnostics to empower providers, payers and patients. The lessons learnt from the COVID 19 Pandemic in 2020, 2021 has emphasized of building blocks of health systems such as timely health service delivery, attention to health workforce, need or robust health information systems, access to diagnostics (analogous to essential medicines), equitable and efficient supply chain for procurement and supplies, both, seamless communication and interconnectedness, financing, leadership and governance. The COVID-19 pandemic has emphasized about the crucial role of diagnostics in health care and that without access to diagnostics, delivery of universal health coverage, antimicrobial resistance mitigation, and pandemic preparedness cannot be achieved. The demand for testing in the pandemic has fueled online commerce demand, forcing IVD companies, OEMs, distributors, laboratories to strategize its business operations differently. The new retail business models in e commerce marketplace such as B2B, B2B2C, B2C are redefining the in vitro diagnostics market. It enables global IVD OEMs, distributors, suppliers, laboratories, e- pharmacies to supply and healthcare institutions, hospitals, clinics, and other healthcare facilities to purchase diagnostic tests, medical equipment and supplies through online channels. In Vitro Diagnostic E-commerce includes buying, selling, leasing, outsourcing of diagnostic equipment, instruments, diagnostic tests, POCT devices and service information which offers advantages such as convenience, lower prices & discounts, across wide range of products, replacement & refund policies, reviews & feedbacks, and quality certifications, thus providing seamless, real time access to R&D, Manufacturing , Supply chain functions of organizations, saving time, connects for quality, state-of-art equipment and products ( and service information). The IVD market is buoyant due to high demand in products, molecular diagnostics, immunoassays, POCT in chronic diseases, rise in consumerization and telehealth (tele-pharmacy), all are strongly pushing it towards further digitalization with latest technology such as AI, ML, IoT. The study will unravel all the strategies and market models for success in E commerce marketplace and online platforms
More Information
Industries Healthcare
No Index No
Is Prebook Yes
Podcast No
WIP Number K789-01-00-00-00